2023-09-28 |
2023-09-27 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
2,500
+4.5%
1.02
2,550
USD
|
2,500
+4.5%
|
1.02
|
2,550
USD
|
|
2023-09-27 |
2023-09-26 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
2,500
+4.7%
0.90
2,250
USD
|
2,500
+4.7%
|
0.90
|
2,250
USD
|
|
2023-04-27 |
2023-04-26 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
1,497
+27.2%
1.77
2,650
USD
|
1,497
+27.2%
|
1.77
|
2,650
USD
|
|
2023-04-26 |
2023-04-25 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
1,315
+31.3%
1.89
2,485
USD
|
1,315
+31.3%
|
1.89
|
2,485
USD
|
|
2022-07-27 |
2022-07-27 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
2,500
+1.1%
0.38
950
USD
|
2,500
+1.1%
|
0.38
|
950
USD
|
|
2022-07-26 |
2022-07-26 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
2,500
+1.1%
0.37
935
USD
|
2,500
+1.1%
|
0.37
|
935
USD
|
|
2022-07-26 |
2022-07-26 |
B
Purchase
|
Hamill John P.
SVP & CFO
Officer
|
3,000
+4.3%
0.37
1,100
USD
|
3,000
+4.3%
|
0.37
|
1,100
USD
|
|
2022-07-05 |
2022-06-30 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
4,500
+2.1%
0.43
1,926
USD
|
4,500
+2.1%
|
0.43
|
1,926
USD
|
|
2022-03-17 |
2022-03-16 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
2,000
+1.0%
0.98
1,960
USD
|
2,000
+1.0%
|
0.98
|
1,960
USD
|
|
2022-03-15 |
2022-03-15 |
B
Purchase
|
Simonson Steven
SVP, Chief Medical Officer
Officer
|
5,000
+6.4%
1.00
4,999
USD
|
5,000
+6.4%
|
1.00
|
4,999
USD
|
|
2022-03-15 |
2022-03-15 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
3,000
+1.5%
0.98
2,940
USD
|
3,000
+1.5%
|
0.98
|
2,940
USD
|
|
2022-01-10 |
2021-12-30 |
S
Sale
|
Bioengine Capital Inc.
Major owner
|
1,239,088
-100.0%
1.60
1,982,541
USD
|
1,239,088
-100.0%
|
1.60
|
1,982,541
USD
|
|
2022-01-10 |
2021-12-30 |
B
Purchase
|
Center Laboratories, Inc.
Major owner
|
1,239,088
+inf%
1.60
1,982,541
USD
|
1,239,088
+inf%
|
1.60
|
1,982,541
USD
|
|
2021-11-22 |
2021-11-19 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
930
+2.5%
1.60
1,488
USD
|
930
+2.5%
|
1.60
|
1,488
USD
|
|
2021-11-18 |
2021-11-18 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
930
+2.6%
1.61
1,497
USD
|
930
+2.6%
|
1.61
|
1,497
USD
|
|
2021-10-25 |
2021-10-22 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
3,000
+9.0%
1.90
5,700
USD
|
3,000
+9.0%
|
1.90
|
5,700
USD
|
|
2021-10-19 |
2021-10-19 |
B
Purchase
|
Huang James
Non-Executive Director
|
50,000
+20.7%
1.90
95,135
USD
|
50,000
+20.7%
|
1.90
|
95,135
USD
|
|
2021-10-19 |
2021-10-19 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
3,000
+9.9%
1.91
5,730
USD
|
3,000
+9.9%
|
1.91
|
5,730
USD
|
|
2021-04-20 |
2021-04-16 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
1,000
+3.4%
2.09
2,092
USD
|
1,000
+3.4%
|
2.09
|
2,092
USD
|
|
2021-04-19 |
2021-04-15 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
1,000
+3.5%
2.24
2,240
USD
|
1,000
+3.5%
|
2.24
|
2,240
USD
|
|
2021-04-07 |
2021-04-06 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
500
+1.8%
2.57
1,285
USD
|
500
+1.8%
|
2.57
|
1,285
USD
|
|
2021-04-06 |
2021-04-05 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
1,000
+3.7%
2.58
2,580
USD
|
1,000
+3.7%
|
2.58
|
2,580
USD
|
|
2021-04-05 |
2021-04-01 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
500
+1.9%
2.46
1,229
USD
|
500
+1.9%
|
2.46
|
1,229
USD
|
|
2021-04-02 |
2021-03-31 |
B
Purchase
|
Huang James
Non-Executive Director
Major owner
|
150,000
+714.3%
2.36
354,000
USD
|
150,000
+714.3%
|
2.36
|
354,000
USD
|
|
2021-03-25 |
2021-03-25 |
B
Purchase
|
Hamill John P.
SVP & CFO
Officer
|
1,500
+150.0%
3.25
4,875
USD
|
1,500
+150.0%
|
3.25
|
4,875
USD
|
|
2021-03-25 |
2021-03-25 |
B
Purchase
|
Simonson Steven
SVP, Chief Medical Officer
Officer
|
1,500
+13.9%
3.25
4,875
USD
|
1,500
+13.9%
|
3.25
|
4,875
USD
|
|
2021-03-25 |
2021-03-25 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
1,500
+6.2%
3.25
4,875
USD
|
1,500
+6.2%
|
3.25
|
4,875
USD
|
|
2020-10-29 |
2020-10-28 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
250
+1.0%
6.56
1,640
USD
|
250
+1.0%
|
6.56
|
1,640
USD
|
|
2020-10-27 |
2020-10-23 |
B
Purchase
|
Huang James
Non-Executive Director
Major owner
|
1,000
+5.0%
6.67
6,666
USD
|
1,000
+5.0%
|
6.67
|
6,666
USD
|
|
2020-10-13 |
2020-10-09 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
250
+1.1%
5.83
1,456
USD
|
250
+1.1%
|
5.83
|
1,456
USD
|
|
2020-10-09 |
2020-10-08 |
B
Purchase
|
Curtis Eric
SVP & COO
Officer
|
500
+inf%
5.27
2,635
USD
|
500
+inf%
|
5.27
|
2,635
USD
|
|
2020-10-09 |
2020-10-07 |
B
Purchase
|
Hamill John P.
SVP & CFO
Officer
|
1,000
+inf%
5.27
5,270
USD
|
1,000
+inf%
|
5.27
|
5,270
USD
|
|
2020-10-09 |
2020-10-07 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
250
+1.1%
5.17
1,293
USD
|
250
+1.1%
|
5.17
|
1,293
USD
|
|
2020-06-05 |
2020-06-04 |
B
Purchase
|
Huang James
Non-Executive Director
Major owner
|
12,200
+152.5%
7.32
89,332
USD
|
12,200
+152.5%
|
7.32
|
89,332
USD
|
|
2020-06-05 |
2020-06-03 |
B
Purchase
|
Huang James
Non-Executive Director
Major owner
|
200
+2.6%
7.42
1,484
USD
|
200
+2.6%
|
7.42
|
1,484
USD
|
|
2020-05-27 |
2020-05-22 |
B
Purchase
|
Tattory John A
SVP & CFO
Officer
|
449
+5.1%
7.25
3,255
USD
|
449
+5.1%
|
7.25
|
3,255
USD
|
|
2020-05-27 |
2020-05-22 |
B
Purchase
|
Schreiber Brian D
Non-Executive Director
|
2,069
+inf%
7.25
15,000
USD
|
2,069
+inf%
|
7.25
|
15,000
USD
|
|
2020-05-27 |
2020-05-22 |
B
Purchase
|
PEACOCK BRUCE
Non-Executive Director
|
3,500
+65.0%
7.25
25,375
USD
|
3,500
+65.0%
|
7.25
|
25,375
USD
|
|
2020-05-27 |
2020-05-22 |
B
Purchase
|
Templeton Mary B Esq
SVP, Gen Counsel & Corp Sec
Officer
|
1,103
+3558.1%
7.25
7,997
USD
|
1,103
+3558.1%
|
7.25
|
7,997
USD
|
|
2020-05-27 |
2020-05-22 |
B
Purchase
|
Huang James
Non-Executive Director
Major owner
|
275,862
+13.4%
7.25
2,000,000
USD
|
275,862
+13.4%
|
7.25
|
2,000,000
USD
|
|
2020-05-27 |
2020-05-22 |
B
Purchase
|
Joseph Mahady M
Non-Executive Director
|
2,069
+38.4%
7.25
15,000
USD
|
2,069
+38.4%
|
7.25
|
15,000
USD
|
|
2020-05-27 |
2020-05-22 |
B
Purchase
|
Simonson Steven
SVP, Chief Medical Officer
Officer
|
517
+5.0%
7.25
3,748
USD
|
517
+5.0%
|
7.25
|
3,748
USD
|
|
2020-05-27 |
2020-05-22 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
2,069
+9.6%
7.25
15,000
USD
|
2,069
+9.6%
|
7.25
|
15,000
USD
|
|
2020-05-27 |
2020-05-22 |
B
Purchase
|
Leone John R
Non-Executive Director
|
2,069
+38.3%
7.25
15,000
USD
|
2,069
+38.3%
|
7.25
|
15,000
USD
|
|
2020-05-27 |
2020-05-22 |
B
Purchase
|
Geffken Daniel E.
Non-Executive Director
|
2,069
+inf%
7.25
15,000
USD
|
2,069
+inf%
|
7.25
|
15,000
USD
|
|
2022-01-10 |
2020-05-20 |
B
Purchase
|
Bioengine Capital Inc.
Major owner
|
55,172
+4.7%
7.25
399,997
USD
|
55,172
+4.7%
|
7.25
|
399,997
USD
|
|
2022-01-10 |
2020-05-20 |
B
Purchase
|
Center Laboratories, Inc.
Major owner
|
55,172
+4.7%
7.25
399,997
USD
|
55,172
+4.7%
|
7.25
|
399,997
USD
|
|
2020-02-20 |
2020-02-18 |
B
Purchase
|
Huang James
Non-Executive Director
Major owner
|
400
+1.7%
3.84
1,535
USD
|
400
+1.7%
|
3.84
|
1,535
USD
|
|
2020-02-12 |
2020-02-11 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
250
+0.4%
4.10
1,025
USD
|
250
+0.4%
|
4.10
|
1,025
USD
|
|
2020-02-12 |
2020-02-10 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
250
+0.4%
4.10
1,025
USD
|
250
+0.4%
|
4.10
|
1,025
USD
|
|
2020-02-07 |
2020-02-07 |
B
Purchase
|
Huang James
Non-Executive Director
Major owner
|
500
+2.2%
4.05
2,025
USD
|
500
+2.2%
|
4.05
|
2,025
USD
|
|
2020-02-05 |
2020-02-04 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
500
+0.8%
4.24
2,120
USD
|
500
+0.8%
|
4.24
|
2,120
USD
|
|
2020-02-05 |
2020-02-03 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
100
+0.2%
4.20
420
USD
|
100
+0.2%
|
4.20
|
420
USD
|
|
2020-01-21 |
2020-01-17 |
B
Purchase
|
Huang James
Major owner
|
2,000
+9.8%
4.18
8,366
USD
|
2,000
+9.8%
|
4.18
|
8,366
USD
|
|
2020-01-21 |
2020-01-16 |
B
Purchase
|
Huang James
Major owner
|
58
+0.3%
4.20
244
USD
|
58
+0.3%
|
4.20
|
244
USD
|
|
2020-01-03 |
2019-12-31 |
B
Purchase
|
Huang James
Major owner
|
15,442
+308.8%
4.05
62,525
USD
|
15,442
+308.8%
|
4.05
|
62,525
USD
|
|
2019-12-31 |
2019-12-30 |
B
Purchase
|
Huang James
Non-Executive Director
Major owner
|
909
+22.2%
3.81
3,463
USD
|
909
+22.2%
|
3.81
|
3,463
USD
|
|
2019-12-31 |
2019-12-27 |
B
Purchase
|
Huang James
Non-Executive Director
Major owner
|
4,091
+inf%
3.73
15,261
USD
|
4,091
+inf%
|
3.73
|
15,261
USD
|
|
2019-12-10 |
2019-12-06 |
B
Purchase
|
LPH II Investments Ltd
Major owner
|
1,655,629
+70.4%
3.02
5,000,000
USD
|
1,655,629
+70.4%
|
3.02
|
5,000,000
USD
|
|
2019-12-10 |
2019-12-06 |
B
Purchase
|
Huang James
Non-Executive Director
Major owner
|
1,655,629
+36.6%
3.02
5,000,000
USD
|
1,655,629
+36.6%
|
3.02
|
5,000,000
USD
|
|
2019-12-10 |
2019-12-06 |
B
Purchase
|
Lee's Pharmaceutical Holdings Ltd
Major owner
|
1,655,629
+12.9%
3.02
5,000,000
USD
|
1,655,629
+12.9%
|
3.02
|
5,000,000
USD
|
|
2018-04-06 |
2018-04-04 |
B
Purchase
|
Lee's Pharmaceutical Holdings Ltd
Major owner
|
541,667
+23.4%
4.80
2,600,002
USD
|
541,667
+23.4%
|
4.80
|
2,600,002
USD
|
|
2016-11-01 |
2016-10-28 |
B
Purchase
|
Fraser Craig
President and CEO
Executive Director
|
7,500
+inf%
2.05
15,381
USD
|
7,500
+inf%
|
2.05
|
15,381
USD
|
|
2013-02-20 |
2013-02-19 |
B
Purchase
|
Leone John R
Non-Executive Director
|
3,000
+inf%
2.88
8,640
USD
|
3,000
+inf%
|
2.88
|
8,640
USD
|
|
2010-12-21 |
2010-12-17 |
S
Sale
|
LOPEZ DAVID L
Executive VP & Legal Counsel
Officer
|
16,300
-5.9%
0.21
3,449
USD
|
16,300
-5.9%
|
0.21
|
3,449
USD
|
|
2010-12-21 |
2010-12-17 |
S
Sale
|
LOPEZ DAVID L
Executive VP & Legal Counsel
Officer
|
700
-0.3%
0.21
148
USD
|
700
-0.3%
|
0.21
|
148
USD
|
|
2008-11-20 |
2008-11-20 |
B
Purchase
|
ROSENTHALE MARVIN E
Non-Executive Director
|
14,674
+7.0%
0.90
13,133
USD
|
14,674
+7.0%
|
0.90
|
13,133
USD
|
|
2008-11-20 |
2008-11-20 |
B
Purchase
|
ROSENTHALE MARVIN E
Non-Executive Director
|
500
+0.4%
0.91
453
USD
|
500
+0.4%
|
0.91
|
453
USD
|
|
2008-11-20 |
2008-11-19 |
B
Purchase
|
ROSENTHALE MARVIN E
Non-Executive Director
|
9,655
+4.8%
0.93
8,979
USD
|
9,655
+4.8%
|
0.93
|
8,979
USD
|
|
2008-11-20 |
2008-11-19 |
B
Purchase
|
ROSENTHALE MARVIN E
Non-Executive Director
|
23,400
+23.1%
0.93
21,762
USD
|
23,400
+23.1%
|
0.93
|
21,762
USD
|
|
2008-11-20 |
2008-11-18 |
B
Purchase
|
ROSENTHALE MARVIN E
Non-Executive Director
|
25,671
+14.7%
1.00
25,671
USD
|
25,671
+14.7%
|
1.00
|
25,671
USD
|
|
2008-11-20 |
2008-11-18 |
B
Purchase
|
ROSENTHALE MARVIN E
Non-Executive Director
|
1,100
+1.1%
1.00
1,100
USD
|
1,100
+1.1%
|
1.00
|
1,100
USD
|
|
2008-11-17 |
2008-11-17 |
B
Purchase
|
CAPETOLA ROBERT J
President/CEO
Executive Director
|
40,000
+10.1%
1.01
40,400
USD
|
40,000
+10.1%
|
1.01
|
40,400
USD
|
|
2008-11-17 |
2008-11-17 |
B
Purchase
|
CAPETOLA ROBERT J
President/CEO
Executive Director
|
10,000
+2.3%
1.05
10,450
USD
|
10,000
+2.3%
|
1.05
|
10,450
USD
|
|
2008-11-14 |
2008-11-14 |
B
Purchase
|
CAPETOLA ROBERT J
President/CEO
Executive Director
|
10,000
+2.6%
1.12
11,200
USD
|
10,000
+2.6%
|
1.12
|
11,200
USD
|
|